Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Journal of Complementary and Integrative Medicine

Editor-in-Chief: Lui, Edmund

Ed. by Ko, Robert / Leung, Kelvin Sze-Yin / Saunders, Paul / Suntres, PH. D., Zacharias

CiteScore 2017: 1.41

SCImago Journal Rank (SJR) 2017: 0.472
Source Normalized Impact per Paper (SNIP) 2017: 0.564

See all formats and pricing
More options …

Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) extract with doxorubicin in human pancreatic, breast and prostate cancer cell lines

Govind J. Kapadia / G. Subba Rao / Cheppail Ramachandran / Akira Iida / Nobutaka Suzuki / Harukuni Tokuda
Published Online: 2013-06-26 | DOI: https://doi.org/10.1515/jcim-2013-0007


Although a wide variety of cytotoxic plant extracts and phytochemicals are known to act synergistically with anticancer drug doxorubicin (D), their clinical application is hindered by safety concerns of such combination therapy. Our earlier studies showed that red beetroot (Beta vulgaris L.) extract (B), approved by Food and Drug Administration and European Union as red food color E162, reduced multi-organ tumor formations in various animal models when administered in drinking water. This led us to postulate that a long-term daily exposure to low doses of B through diet might be safe and sufficient to produce cancer chemopreventive effect in humans. Further, our recent comparative cytotoxic investigation with B and D in several human cancer cell lines indicated their potential for synergistic activity. Since B is considered safe for human use with no known toxicity, we conducted the present study to evaluate its synergistic antiproliferative activity with D against pancreatic (PaCa), breast (MCF-7) and prostate (PC-3) tumor cells of human origin. Different concentrations of B and D (0.29–290 μg/ml) and in various combinations (B:D ratio = 1:0, 1:1, 5:1, 1:5 and 0:1) were tested for cytotoxic effects against the three cancer cells. The viability of cells was assessed after 72 h incubation with various combinations of B and D using the trypan-blue staining method. The cytotoxic data were analyzed by the combination index method of Chou and Talalay to establish synergy between B and D. The results indicated that an overall positive reduction in drug concentration was achieved by D when combined with B in its cytotoxicity profile in the three human cancer cells tested. The synergistic cytotoxicity was best when the B:D ratio of 1:5 was used in PaCa cells at IC50, IC75 and IC90 dose levels and in MCF-7 cells at IC90 dose level. These results warrant further studies on the potential of red beetroot extract–doxorubicin combination in treating human cancers.

Keywords: red beetroot extract; food color E162; doxorubicin (Adriamycin); synergistic cytotoxicity; human PaCa; PC-3; MCF-7 cancer cells


  • 1.

    Government of India, Ministry of Health and Family Welfare. The Ayurvedic Pharmacopoeia of India, Parts I and II. New Delhi: Government of India Press, 1978 and 2007.Google Scholar

  • 2.

    Bensky D, Gamble A. Chinese herbal medicine: materia medica, rev. ed. Seattle, WA: Eastland Press, 1993.Google Scholar

  • 3.

    Patwardhan B, Warude D, Pushpnagadan P, Bhat N. Ayurveda and traditional Chinese medicine: a comparative overview. Evid Based Complement Alternat Med 2005;2:465–73.Google Scholar

  • 4.

    Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism of drug combination studies. Pharmacol Rev 2006;58:621–81.PubMedCrossrefGoogle Scholar

  • 5.

    Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 2010;70:440–6.CrossrefPubMedGoogle Scholar

  • 6.

    Ulrich-Merzenich G, Panek D, Zeitler H, Vetter H, Wagner H. Drug development from natural products: exploiting synergistic effects. Indian J Exp Biol 2010;48:208–19.Google Scholar

  • 7.

    Tanos V, Brzezinski A, Drize O, Strauss N, Peretz T. Synergistic inhibitory effects of genistein and tamoxifen on human dysplastic and malignant epithelial breast cells in vitro. Eur J Obstet Gynecol Reprod Biol 2002;102:188–94.CrossrefGoogle Scholar

  • 8.

    Wang MY, West BJ, Jensen CJ, Nowicki D, Chen SU, Palu AK, et al. Morinda citrifolia (Noni): A literature review and recent advances in Noni research. Acta Pharmacol Sin 2002:12:1127–47.Google Scholar

  • 9.

    Sharma G, Tyagi AK, Singh RP, Chan DC, Agarwal R. Synergistic anticancer effects of grape seed extract and conventional cytotoxic agent doxorubicin against human breast carcinoma cells. Breast Cancer Res Treat 2004;85:1–12.CrossrefGoogle Scholar

  • 10.

    Tyagi AK, Agarwal C, Chan DC, Agarwal R. Synergistic anticancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells. Oncol Res 2004;11:493–9.Google Scholar

  • 11.

    Hemaiswarya S, Doble M. Potential synergism of natural products in the treatment of cancer. Phytother Res 2006;20:239–49.PubMedCrossrefGoogle Scholar

  • 12.

    Wang CZ, Luo X, Zhang B, Song WX, Ni M, Mehendale S, et al. Notoginseng enhances anti-cancer effects of 5-fluorouracil on human colorectal cancer cells. Cancer Chemother Pharmacol 2007;60:69–79.PubMedCrossrefGoogle Scholar

  • 13.

    Wei J, Liu B, Wang L, Qian X, Ding Y, Yu L. Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on therapeutic agent-associated genes in human gastric cancer cell lines. Cancer Chemother Pharmacol 2007;60:703–11.CrossrefPubMedGoogle Scholar

  • 14.

    Akao Y, Nakagawa Y, Inuma M, Nozawa Y. Anti-cancer effects of xanthones from pericarps of mangosteen: Int J Mol Sci 2008;9:355–70.CrossrefPubMedGoogle Scholar

  • 15.

    Banerjee S, Kaseb AO, Wang Z, Kong D, Mohammad M, Padhye S, et al. Antitumor activity of gemcitabine and oxaliplatin is augmented by thymoquinone in pancreatic cells. Cancer Res 2009;69:5575–83.CrossrefPubMedGoogle Scholar

  • 16.

    Griggs JJ. Reducing the toxicity of anticancer therapy: new strategies. Leuk Res 1998;22(Suppl 1):S27–33.CrossrefGoogle Scholar

  • 17.

    Borek C. Dietary antioxidants and human cancer. Integr Cancer Ther 2004;3:333–41.PubMedCrossrefGoogle Scholar

  • 18.

    Liu HR. Potential synergy of phytochemicals in cancer prevention: mechanisms of action. J Nutr 2004;134:3479S–85S.Google Scholar

  • 19.

    Huang XZ, Wang J, Huang C, Chen YY, Shi GY, Hu QS, Yi J. Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells: the mechanisms involve ROS-mediated suppression of multidrug resistance and hypoxia inducible factor-1. Cancer Biol Ther 2008;7:468–75.PubMedGoogle Scholar

  • 20.

    Chai S, To KKW, Lin G. Circumvention of multi-drug resistance of cancer cells by Chinese herb medicine. Chin Med 2010;5:26–35.CrossrefGoogle Scholar

  • 21.

    Tan W, Lu J, Huang M, Li Y, Chen M, Wu G, et al. Review: anti-cancer natural products isolated from Chinese medicinal herbs. Chin Med 2011;6:27–42.CrossrefGoogle Scholar

  • 22.

    Lown JW. Anthracycline and anthraquinone anticancer agents. Current status and recent developments. Pharmacol Ther 1993;60:185–214.CrossrefPubMedGoogle Scholar

  • 23.

    Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS, Moreira PI. Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 2009;16:3267–85.CrossrefPubMedGoogle Scholar

  • 24.

    Abdel-Wahab MH, El-Mahdy MA, Abd-Ellah MF, Helat GK, Khalifa F, Hamada FMA. Influence of p-coumaric acid on doxorubicin-induced oxidative stress in rat’s heart. Pharmacol Res 2003;48:461–5.CrossrefGoogle Scholar

  • 25.

    Psotova J, Chlopcikova S, Miketova P, Hrbac J, Simanek V. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part III. Apigenin, baicalenin, kaempherol, luteolin and quercetin. Phytother Res 2004;18:516–21.PubMedCrossrefGoogle Scholar

  • 26.

    Teiten MH, Eifes S, Dicato M, Diedrich M. Review: Curcumin – the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins 2010;2:128–62.CrossrefGoogle Scholar

  • 27.

    Ravizza R, Gariboldi MB, Molteni R, Monti E. Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells. Oncol Rep 2008;20:625–30.PubMedGoogle Scholar

  • 28.

    Effenberger K, Schobert R. Combinational effects of thymoquinone on the anti-cancer activity of doxorubicin. Cancer Chemother Pharmacol 2010;67:867–74.Google Scholar

  • 29.

    Kaneez FS, Al-Salam S, Alaaeldin AH. Sesame oil as a protective agent against doxorubicin induced cardiotoxicity in rat. Am J Pharmacol Toxicol 2007;2:159–63.Google Scholar

  • 30.

    Alkreathy H, Damanhouri ZA, Ahmed N, Slevin M, Ali SS and Osman AMM. Aged garlic extract protects against doxorubicin-induced cardiotoxicity in rats. Food Chem Toxicol 2010;48:951–6.CrossrefGoogle Scholar

  • 31.

    Liu TJ, Yeh YC, Ting CT, Lee WL, Wang LC, Lee HW, et al. Ginkgo biloba extract 761 reduces doxorubicin-induced apoptoic damage in rat hearts and neonatal cardiomyocytes. Cardiovasc Res 2008;80:227–35.CrossrefGoogle Scholar

  • 32.

    Wattanapitayakul SK, Chularojmontri L, Herunsalee A, Charuchongkolwongse S, Niumsakul S, Bauer JA. Screening of antioxidants from medicinal plants for cardioprotective effect against doxorubicin toxicity. Basic Clin Pharmacol Toxicol 2005;96:80–7.CrossrefPubMedGoogle Scholar

  • 33.

    Breibart E. Effects of water-soluble antioxidants from spinach, NAO, on doxorubicin-induced heart injury. Hum Exp Toxicol 2001;20:337–45.CrossrefGoogle Scholar

  • 34.

    Liang G, Tang A, Lin X, Li L, Zhang S, Huang Z, et al. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol 2010;37:111–23.Google Scholar

  • 35.

    Sarkar A, Sreenivasan Y, Ramesh GT, Manna SK. D-Glucoside suppresses tumor necrosis factor-induced activation of nuclear transcription factor kB but potentiates apoptosis. J Biol Chem 2004;279:33768–81.CrossrefGoogle Scholar

  • 36.

    Kolarovic J, Popovic M, Zlinska J, Trivic S, Vojnovic M. Antioxidant activities of celery and parsley juices in rats treated with doxorubicin. Molecules 2010;15:6193–204.PubMedCrossrefGoogle Scholar

  • 37.

    Nair PKR, Melnick S, Wnuk SF, Rapp M, Escalon E, Ramachandran C. Isolation and Characterization of an anticancer catechol compound from Semecarpus anacradium. J Ethnopharmacol 2009;122:450–6.CrossrefPubMedGoogle Scholar

  • 38.

    Colombo V, Lupi M, Falcetta F, Forestieri D, D’Incalci M, Ubezio P. Chemotherapeutic activity of silymarin combined with doxorubicin or paclitaxel in sensitive and multidrug-resistant colon cancer cells. Cancer Chemother Pharmacol 2011;67:369–79.PubMedCrossrefGoogle Scholar

  • 39.

    Chen HM, Wu YC, Chia YC, Chang FR, Hsu HK, Hseih YC, et al. Gallic acid, a major component of Toona sinensis leaf extracts, contains ROS-mediated anti-cancer activity in human prostate cancer cells. Cancer Lett 2009;286:161–71.CrossrefGoogle Scholar

  • 40.

    Pandey MK, Sung B, Ahn KS, Kunnumakkara AB, Chaturvedi MM, Aggarwal BB. Gambogic acid, a new ligand for transferring receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kB signaling pathway. Blood 2007;110:3517–25.CrossrefGoogle Scholar

  • 41.

    Scambia G, Ranelletti FO, Panici PB, De Vencenzo R, Bonanno G, Piantelli M, et al. Quercetin potentiates the effect of adriamycin in a multi-drug resistant MCF-7 human breast cancer line: P- glycoprotein as a possible target. Cancer Chemother Pharmacol 1994:34:459–64. Comment by Sarkar MA. Quercetin not only inhibits P-glycoprotein efflux but also inhibits CYP3A isoenzyme. Cancer Chemother Pharmacol 1995:36:448–50.Google Scholar

  • 42.

    Sun AX, Ye XG, Li CY, Xue BY, Li LF, Cao XF, et al. Synergistic anticancer effects of tetrandrine combined with doxorubicin or vincristine in vitro. Acta Pharmacol Sin 1999;20:69–73.Google Scholar

  • 43.

    Chanamahasathein W, Ampasavate C, Greger H, Limtrakul P. Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance. Phytomedicine 2011;18:199–204.CrossrefGoogle Scholar

  • 44.

    Fenig E, Nordenberg J, Beery E, Sulkes J, Wasserman L. Combined effect of aloe-emodin and chemotherapeutic agents on the proliferation of an adherent variant cell line of Merkel cell carcinoma. Oncol Rep 2004;11:213–7.PubMedGoogle Scholar

  • 45.

    Gao RL, Lin XJ, Qian XD, Chen XH, Nu YP. Effect of ginsenosides and panaxatriol extracted from ginseng on inhibition of proliferation, inducing apoptosis and cytotoxic drug sensitivity in leukemic cells. J Chin Med Res 2004;4:97–9.Google Scholar

  • 46.

    Zheng Y, Zhou F, Wu X, Wen X, Li Y, Yan B, et al. 23-Hydroxybetulinic acid from Pulsatilla chinensis (Bunge) Regel synergizes the antitumor activities of doxorubicin in vitro and in vivo. J Ethnopharmacol 2010;128:615–22.CrossrefGoogle Scholar

  • 47.

    Pinmai K, Chunlaratthanabhorn S, Ngamkitidechakul C, Soonthornchareon N, Hahnvajanawong C. Synergistic growth inhibitory effects of Phyllanthus emblica and Terminalia bellerica extracts with conventional cytotoxic agents: Doxorubicin and cisplatin against human hepatocelluar carcinoma and lung cancer cells. World J Gastroenterol 2008;14:1491–7CrossrefGoogle Scholar

  • 48.

    Francis FJ. Safety of food colorants. In: Hendry GAF, Hougton JD, editors. Natural food colorants, 2nd ed. Glasgow: Blackie Academic Professional, 1996:112–30.Google Scholar

  • 49.

    Kapadia GJ, Azuine MA, Rao GS, Arai T, Iida A, Tokuda H. Cytotoxic effect of the red beetroot (Beta vulgaris L.) extract compared to doxorubicin (Adriamycin) in the human prostate (PC-3) and breast (MCF-7) cancer cell lines. Anti-Cancer Agent Med Chem 2011;11:280–4.CrossrefGoogle Scholar

  • 50.

    Kapadia GJ, Rao GS, Elinor-Reid T, Iida A, Suzuki N, Tokuda H. Synergistic cytotoxic effect of red beetroot (Beta vulgaris L.) food colorant E162 with anticancer drug doxorubicin (Adriamycin) against human prostate, breast and pancreatic tumor cells. In: Abstracts of Papers, American Society of Pharmacognosy 52nd Annual Meeting, San Diego, CA, 2011:P241.Google Scholar

  • 51.

    Kapadia GJ, Tokuda H, Konoshima T, Nishino H. Chemoprevention of lung and skin cancer by Beta vulgaris (beet) root extract. Cancer Lett 1996;100:211–4.CrossrefGoogle Scholar

  • 52.

    Kapadia GJ, Azuine MA, Sridhar R, Okuda Y, Tsuruta A, Ichishi E, et al. Chemoprevention of DMBA-induced UV-B promoted, NOR-1-induced TPA promoted skin carcinogenesis and DEN-induced phenobarbital promoted liver tumors in mice by extract of beetroot. Pharmacol Res 2003;47:141–8.Google Scholar

  • 53.

    Kapadia GJ, Rao GS. Anticancer effects of red beet pigments. In: Neelwarne B, editor. Red beet biotechnology: metabolites for food and pharmaceutical applications. New York, NY: Springer 2013:125–54.Google Scholar

  • 54.

    Chou TC, Talalay P. Analysis of combined drug effects: a new look at a very old problem. Trend Pharmacol Sci 1983;4:450–4.CrossrefGoogle Scholar

  • 55.

    Reznikoff CA, Bertram JS, Brankow DW, Heidelberger C. Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to post confluence inhibition of cell division. Cancer Res 1973;33:3239–49.Google Scholar

  • 56.

    Kakunga TA. A quantitative system for assay of malignant trans- formation by chemical carcinogens using a clone of BALB-373. Int J Cancer 1973;12:463–73.CrossrefGoogle Scholar

  • 57.

    Tolnai S. A method for viable cell count. Method Cell Sci 1975;1:37–8.Google Scholar

  • 58.

    Azeredo HMC. Betalains: properties, sources, applications, and stability – a review. Int J Food Sci Technol 2009;44:2365–76.CrossrefGoogle Scholar

  • 59.

    Ferreira ALA, Yeum KJ, Matsubara LS, Matsubara BB, Correa CR, Periera EJ, et al. Doxorubicin as an antioxidant: maintenance of myocardial levels of lycopene under doxorubicin treatment. Free Radic Biol Med 2007;43:740–51.Google Scholar

About the article

Received: 2011-07-27

Accepted: 2012-10-29

Published Online: 2013-06-26

Citation Information: Journal of Complementary and Integrative Medicine, Volume 10, Issue 1, Pages 113–122, ISSN (Online) 1553-3840, ISSN (Print) 2194-6329, DOI: https://doi.org/10.1515/jcim-2013-0007.

Export Citation

©2013 by Walter de Gruyter Berlin / Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Goulnar Kasymjanova, Anh-Thi Tran, Victor Cohen, Carmela Pepe, Lama Sakr, David Small, Jason Scott Agulnik, and Robert Thomas Jagoe
Journal of Integrative Medicine, 2018
Varinder Kaur, Manish Kumar, Ajay Kumar, Kamaldeep Kaur, Varinderpal Singh Dhillon, and Satwinderjeet Kaur
Biomedicine & Pharmacotherapy, 2018, Volume 97, Page 564
Cheppail Ramachandran, Barry Wilk, Steven J. Melnick, and Isaac Eliaz
Evidence-Based Complementary and Alternative Medicine, 2017, Volume 2017, Page 1
Dona Sinha, Jaydip Biswas, Seyed Mohammad Nabavi, and Anupam Bishayee
Seminars in Cancer Biology, 2017
Cheppail Ramachandran, Karl-Werner Quirin, Enrique Escalon, and Steven J. Melnick
Journal of Evidence-Based Complementary & Alternative Medicine, 2014, Volume 19, Number 2, Page 119
Paolino Ninfali, Elena Antonini, Alessandra Frati, and Emanuele-Salvatore Scarpa
Phytotherapy Research, 2017, Volume 31, Number 6, Page 871
Tom Clifford, Costas M. Constantinou, Karen M. Keane, Daniel J. West, Glyn Howatson, and Emma J. Stevenson
European Journal of Nutrition, 2017, Volume 56, Number 3, Page 1245
Cheppail Ramachandran, Gilda M. Portalatin, Adriana M. Prado, Karl-Werner Quirin, Enrique Escalon, and Steven J. Melnick
Journal of Evidence-Based Complementary & Alternative Medicine, 2017, Volume 22, Number 2, Page 260
Yuri N. Clement, Varune Mahase, Annelise Jagroop, Kelly Kissoon, Aarti Maharaj, Prashant Mathura, Chrys Mc Quan, Divya Ramadhin, and Cherrista Mohammed
BMC Complementary and Alternative Medicine, 2016, Volume 16, Number 1
Sofia Nestora, Franck Merlier, Elise Prost, Karsten Haupt, Claire Rossi, and Bernadette Tse Sum Bui
Journal of Chromatography A, 2016, Volume 1465, Page 47
Ejaz Hussain, Li-Jun Wang, Bo Jiang, Saba Riaz, Ghazala Yasmeen Butt, and Da-Yong Shi
RSC Adv., 2016, Volume 6, Number 15, Page 12592
Laëtitia Nowacki, Pascale Vigneron, Laura Rotellini, Hélène Cazzola, Franck Merlier, Elise Prost, Robert Ralanairina, Jean-Pierre Gadonna, Claire Rossi, and Muriel Vayssade
Phytotherapy Research, 2015, Volume 29, Number 12, Page 1964
Limor Almog, Efraim Lev, Elad Schiff, Shai Linn, and Eran Ben-Arye
Supportive Care in Cancer, 2014, Volume 22, Number 10, Page 2793

Comments (0)

Please log in or register to comment.
Log in